Asia Diabetes Foundation
11
1
1
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
9%
1 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Jockey Club Precision Prevention Programme on Young Onset Diabetes
Role: collaborator
Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT)
Role: lead
Comparing the Effect of Structured Care Versus Usual Care in Type 2 Diabetes Patients Across the Asia Pacific Region
Role: lead
Community Health Worker Reduces Care Utilization
Role: collaborator
PEARL Program: Empowerment Program for Patients With Type 2 Diabetes (HK4)
Role: collaborator
Prevalence Study of Depression in Chinese Patients With Type 2 Diabetes (HK13)
Role: collaborator
Evaluation of Morbidities, Endpoints and Reaching Targets in Diabetic Patients Managed by a Diabetes Specialist Team
Role: lead
An Evaluation of the Effectiveness and Acceptability of Delivering Structured Care in Chinese Type 2 Diabetic Patients
Role: lead
Effectiveness of a Treat-to-target Clinic Led by a Nurse Consultants
Role: lead
Establishing a Diabetes Registry Using the JADE-DIAMOND Electronic Portal (CN001)
Role: lead
PLATINUM Program: A Feasibility Study on a Train-the-trainer Course on Peer Support for People With Type 2 Diabetes
Role: lead
All 11 trials loaded